Tekla Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.6M | Sell |
67,506
-16,208
| -19% | -$624K | 0.1% | 104 |
|
|
2023
Q1 | $3M | Hold |
83,714
| – | – | 0.11% | 101 |
|
|
2022
Q4 | $3.3M | Buy |
83,714
+21,981
| +36% | +$867K | 0.12% | 93 |
|
|
2022
Q3 | $2.23M | Buy |
61,733
+32,023
| +108% | +$1.16M | 0.09% | 110 |
|
|
2022
Q2 | $904K | Buy |
+29,710
| New | +$904K | 0.04% | 137 |
|
|
2021
Q4 | – | Sell |
-169,030
| Closed | -$2.58M | – | 183 |
|
|
2021
Q3 | $2.58M | Hold |
169,030
| – | – | 0.08% | 129 |
|
|
2021
Q2 | $3.15M | Buy |
169,030
+3,132
| +2% | +$58.3K | 0.1% | 138 |
|
|
2021
Q1 | $2.97M | Buy |
+165,898
| New | +$2.97M | 0.1% | 149 |
|
|
2020
Q1 | – | Sell |
-96,961
| Closed | -$1.27M | – | 223 |
|
|
2019
Q4 | $1.27M | Buy |
+96,961
| New | +$1.27M | 0.05% | 175 |
|
|
2018
Q3 | – | Sell |
-163,819
| Closed | -$1.51M | – | 214 |
|
|
2018
Q2 | $1.51M | Sell |
163,819
-116,181
| -41% | -$1.07M | 0.06% | 146 |
|
|
2018
Q1 | $1.37M | Sell |
280,000
-70,000
| -20% | -$343K | 0.05% | 151 |
|
|
2017
Q4 | $989K | Hold |
350,000
| – | – | 0.04% | 146 |
|
|
2017
Q3 | $1.03M | Hold |
350,000
| – | – | 0.04% | 136 |
|
|
2017
Q2 | $1.1M | Hold |
350,000
| – | – | 0.04% | 129 |
|
|
2017
Q1 | $1.4M | Sell |
350,000
-350,000
| -50% | -$1.4M | 0.05% | 121 |
|
|
2016
Q4 | $5.39M | Hold |
700,000
| – | – | 0.23% | 77 |
|
|
2016
Q3 | $5.67M | Buy |
+700,000
| New | +$5.67M | 0.22% | 80 |
|